Skip to content

Study note

Hematological status and endurance performance predictors after low altitude training supported by normobaric hypoxia: a double-blind, placebo controlled study.

PMID 31938005 (2019): altitude, hypoxia — VO₂max, Time-trial performance (study note for endurance athletes).

Updated Jul 22, 2026

Read the study note

Study note • PMID 31938005

Hematological status and endurance performance predictors after low altitude training supported by normobaric hypoxia: a double-blind, placebo controlled study.

Biology of sport2019 • DOI 10.5114/biolsport.2019.88760

How to use this page

This note summarizes one study record. Check the participants, methods, results, and limitations before applying it to training.

  • Design signal: controlled study.
  • Population relevance: athlete/trained context.
  • Consistency: single-study evidence.
  • Practical recommendation depends on tolerance, context, and whether it protects training consistency.

ELI5

In plain language

The benefits of altitude/hypoxic training for sea level performance are still under debate. (controlled study; n=8 elite cyclists).

The abstract suggests a positive effect on Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: The benefits of altitude/hypoxic training for sea level performance are still under debate.
  • The abstract suggests a positive effect on Time-trial performance under the tested conditions.
  • Population: n=8 elite cyclists.
  • Protocol cues (title/abstract): 3 weeks • 2 weeks • 1100 m • 2200 m • 1000 m.

Protocol

Protocol (as reported)

  • Intervention/exposure: altitude, hypoxia (vs placebo).
  • Dose/time/duration cues in abstract/title: 3 weeks • 2 weeks • 1100 m • 2200 m • 1000 m.
  • Outcomes: VO₂max, Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it may help, and who should be cautious

Who it helps

  • Athletes similar to the study population (n=8 elite cyclists) working on altitude.
  • Athletes who can measure VO₂max, Time-trial performance with a repeatable workout or time-trial effort.

Who should be cautious

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: controlled study (placebo-controlled).
  • Population: n=8 elite cyclists.
  • Comparator: placebo.
  • Outcomes measured: VO₂max, Time-trial performance.
  • Protocol cues mentioned: 3 weeks • 2 weeks • 1100 m • 2200 m • 1000 m.
  • Source: PubMed PMID 31938005 (2019) — Biology of sport.

Results excerpt

What the abstract reports

However, these effects were not associated with normobaric hypoxia.

Note: excerpts are short; for full context, read the paper.

Limits

Limitations and bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Adaptive AI coach for iPhone

Meet your adaptive AI coach.

Tell your coach what you are training for. It builds the plan, follows the work you complete, and adapts upcoming training when recovery, your schedule, or real life changes.

Keep going

Sources